What Is GERD

Gastroesophageal reflux disease (GERD) is a chronic digestive condition in which stomach acid or bile repeatedly flows back into the esophagus, irritating its lining. The lower esophageal sphincter, a ring of muscle that normally prevents backflow, fails to close properly or relaxes at inappropriate times. When this happens regularly, it can produce sustained inflammation, tissue erosion, and a range of symptoms that extend well beyond simple heartburn.

GERD matters for long-term health because the esophagus lacks the protective mucus barrier that the stomach relies on. Repeated acid exposure damages the esophageal epithelium, creating chronic low-grade inflammation that can compound over decades. This persistent inflammatory state does not remain local; it affects nutrient absorption, sleep quality, vagal tone, and the broader gastrointestinal ecosystem. For anyone focused on extending healthspan, an unresolved reflux problem introduces a continuous source of tissue damage and systemic stress.

The condition also intersects with several hallmarks of aging. Chronic mucosal inflammation accelerates cellular turnover and can promote dysplastic tissue changes. Impaired digestion from reduced acid (whether from the disease process itself or from acid-suppressing medications) compromises the absorption of minerals like magnesium, calcium, and iron, as well as B vitamins. Over time, these deficiencies undermine bone density, mitochondrial function, and methylation capacity. Addressing GERD is not merely about comfort; it is about preserving the integrity of a system that the rest of the body depends on for fuel and raw materials.

The primary gatekeeper against reflux is the lower esophageal sphincter (LES), a tonically contracted band of smooth muscle at the junction of the esophagus and stomach. Under normal conditions, the LES relaxes during swallowing to allow food passage and then re-contracts. In GERD, the LES either loses baseline tone or undergoes transient inappropriate relaxations, allowing gastric contents to contact the esophageal mucosa. Contributing factors include hiatal hernia (where part of the stomach protrudes above the diaphragm, altering the geometry of the LES), increased intra-abdominal pressure from visceral fat, and impaired esophageal clearance.

The acidity of gastric contents, typically at a pH between 1.5 and 3.5, is what causes mucosal injury. Pepsin, a proteolytic enzyme activated by acid, can adhere to the esophageal lining and continue to inflict damage even after the acid event passes. In some individuals, bile reflux from the duodenum adds alkaline injury to the picture. The combined insult triggers an inflammatory cascade involving cytokines such as interleukin-8, recruitment of neutrophils and lymphocytes, and eventual disruption of the epithelial barrier. Over time, the body may attempt to protect itself through metaplasia, replacing the normal squamous epithelium with columnar cells more typical of the intestinal lining, a condition known as Barrett's esophagus.

Beyond the local tissue response, GERD also affects the vagus nerve, which runs along the esophagus. Chronic irritation of vagal afferents can alter autonomic signaling, contributing to symptoms like chronic cough, laryngeal spasm, and even cardiac arrhythmias in some cases. The vagal connection also means that GERD can influence motility throughout the gastrointestinal tract, contributing to delayed gastric emptying and downstream dysbiosis.

The classic presentation of GERD includes a burning sensation behind the sternum (heartburn) that worsens after meals or when lying down, and regurgitation of sour or bitter liquid into the throat. These symptoms are familiar to most people, but GERD can also present atypically, making it easy to overlook. Chronic dry cough, persistent throat clearing, hoarseness (especially in the morning), and a sensation of a lump in the throat (globus) are all potential indicators of laryngopharyngeal reflux, where acid reaches the upper airway without producing classic heartburn.

Dental erosion, particularly on the inner surfaces of the upper teeth, is a signal that acid has been reaching the oral cavity during sleep. Disrupted sleep itself can be both a symptom and an amplifier: nighttime reflux events fragment sleep architecture, while poor sleep increases stress hormones that further impair LES function. Bloating, excessive belching, and a sensation of food sitting heavily in the stomach may point toward impaired gastric emptying or insufficient acid production as contributing factors rather than simple acid excess.

Esophagogastroduodenoscopy (EGD) remains the standard for visualizing esophageal damage, identifying Barrett's esophagus, and ruling out malignancy. Biopsies taken during endoscopy can reveal the degree of inflammation and whether metaplastic changes have occurred. For patients whose symptoms do not clearly correlate with acid exposure, ambulatory pH monitoring (either catheter-based or wireless capsule) provides 24 to 48 hours of objective data on acid contact time in the esophagus.

Esophageal manometry measures the pressure and coordination of esophageal contractions and LES function, which is particularly useful when surgical intervention is being considered or when symptoms suggest a motility disorder. From a functional perspective, the Heidelberg pH capsule test can assess gastric acid production to determine whether hypochlorhydria may be contributing. Comprehensive stool testing (such as the GI-MAP) can identify H. pylori, dysbiosis, and markers of digestive insufficiency that may be fueling the reflux cycle from further down the tract. Food sensitivity panels, while debated in terms of clinical validity, are sometimes used to identify dietary triggers that standard elimination diets may miss.

Restoration begins with the mechanical and behavioral foundations: reducing meal volume, avoiding recumbent positions after eating, and addressing excess abdominal pressure through body composition changes when relevant. Elevating the head of the bed is one of the most consistently supported non-pharmacological interventions, as it leverages gravity to reduce nocturnal acid contact time.

Once basic triggers are managed, attention shifts to the mucosal environment. Demulcent herbs such as slippery elm, deglycyrrhizinated licorice (DGL), and aloe vera gel have a long history of traditional use for soothing irritated mucosa, and some small clinical studies support their symptom-relieving effects. Zinc carnosine has been studied for its ability to support gastric mucosal repair and may be particularly useful during the transition off acid-suppressing medications. If H. pylori is identified, eradication protocols should be considered, as this organism can alter gastric acid dynamics in both directions depending on its location within the stomach.

For individuals with confirmed or suspected low stomach acid, a supervised trial of betaine HCl at meals can help determine whether acid supplementation improves digestion and reduces reflux. Digestive enzyme supplementation may complement this approach, particularly for those with pancreatic insufficiency or bile acid issues. Rebuilding the broader gut ecosystem with targeted probiotics (especially Lactobacillus and Bifidobacterium strains studied in reflux contexts), prebiotic fibers, and fermented foods can support motility and reduce the gas-producing fermentation that sometimes drives reflux from below.

The conventional understanding of GERD, centered on excess acid and LES dysfunction, is supported by decades of clinical research including large randomized trials of proton pump inhibitors and H2 receptor antagonists. These drugs reliably reduce symptoms and promote mucosal healing in the majority of patients. However, observational and cohort studies have raised concerns about long-term PPI use, including associations with increased risk of chronic kidney disease, dementia, bone fractures, and enteric infections. These associations remain under active investigation and have not been confirmed as causal in randomized settings.

The hypothesis that some GERD cases involve low rather than high stomach acid has received less formal study but has clinical traction in functional medicine settings. Small trials and clinical observations suggest that supplemental hydrochloric acid (as betaine HCl) can reduce symptoms in selected patients, particularly those with concurrent SIBO or hypochlorhydria. Research into the role of the microbiome in GERD is still early, but preliminary studies have identified differences in esophageal and gastric microbial communities between GERD patients and controls. The connection between visceral adiposity and reflux is well established in epidemiological data, with weight loss consistently shown to reduce symptom burden. Overall, the mechanistic picture is more nuanced than the simple acid-excess model suggests, and individualized assessment remains important.

Abruptly discontinuing proton pump inhibitors after long-term use can trigger rebound acid hypersecretion, temporarily worsening symptoms. Any trial of betaine HCl or acid supplementation should be avoided in the presence of active ulcers, erosive esophagitis, or concurrent NSAID use. Chronic untreated GERD carries the risk of esophageal stricture, Barrett's esophagus, and, in rare cases, esophageal adenocarcinoma. People with alarm symptoms such as difficulty swallowing, unintentional weight loss, or gastrointestinal bleeding should seek diagnostic evaluation before pursuing lifestyle or supplement-based approaches.